The U.S. Food and Drug Administration (FDA) has approved revumenib, a pioneering drug for relapsed or refractory acute ...

The US Food and Drug Administration (FDA) has granted accelerated approval to Ziihera (zanidatamab-hrii), a novel therapy for ...

ONCOLife proudly presents an exclusive interview with Dr. Iris Kuss, VP and Global Development Lead Oncology at Bayer. In ...

Oncolytic viruses are a very promising class of therapeutic agents, with a broad range of types. In this exclusive interview ...

Researchers from Cambridge University Hospitals, in collaboration with the NHS Health Research Authority, have launched the ...

The FDA has approved Caris Life Sciences’ MI Cancer Seek, a pioneering diagnostic test combining Whole Exome and Whole ...

Antibody-drug conjugates (ADCs) represent a significant breakthrough in oncology, offering targeted treatments, especially for lung cancer. In this insightful interview with Dr. Nicolas Girard, Head ...

Comprehensive Genomic Profiling (CGP) is reshaping cancer treatment by enabling precision oncology at an unprecedented scale. Dr. Lucio N. Gordan, President and Managing Physician at the Florida ...

Don't miss this opportunity to hear their insights and get answers to your questions on how AI is shaping the future of healthcare. The general overview of your report, "AI In Pharmaceuticals Promises ...

This novel DNA plasmid vaccine targets antigen-presenting cells and aims to induce a robust immune response. Prof. Lindy Durrant, CEO of Scancell, shared insights from the latest Phase 2 SCOPE trial ...